The new Engineered Biosystems Building will be a giant leap forward in creating the infrastructure that inspires and sustains scientific discovery at Georgia Tech. EBB will enable us to expand our commitment to improving and saving lives by providing bringing new treatments, medical technologies, medications, and therapies to patients.  The key to innovation lies in collaboration, and the EBB is designed to facilitate research across disciplinary and institutional boundaries. Partnerships are integral to the success of EBB, especially between faculty from the Colleges of Sciences, Engineering, Computing, and between Georgia Tech researchers and those from Emory University, Children’s Healthcare of Atlanta, and other institutions. The research conducted in EBB will help distinguish Georgia Tech as a national leader in biomedicine and biotechnology.

EBB will provide 200,000 square feet of technologically advanced laboratories for faculty, researchers, and students to pursue Georgia Tech’s growing research agenda in the biological sciences. The building will also strengthen the Georgia Tech’s ability to attract and retain the best faculty from around the world. It will allow the College of Sciences to increase the size of its faculty in Biology over the next decade. In turn, these exceptional teacher-scholars will draw the brightest, most talented graduate students to Tech. Moreover, EBB will significantly enhance Georgia Tech’s commercialization efforts, stimulate job growth in the state, and generate new startup companies.